X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Innovation Pharmaceuticals (OTCQB:IPIX +5.6%) announces data generated at a "leading" public health research institute that showed Brilacidin's dose-dependent inhibitory effect on SARS-CoV-2 c... [Read More]
Save As
Preview
Preview